Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

26 participants · First posted Jul 31, 2020

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

26 participants · First posted Jun 3, 2009

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

First posted Jul 15, 2009

ARAC

DeVal (Innovus Pharmaceuticals, Inc.)

Yagin (Savient Pharmaceuticals, Inc.)

Mezzion Pharma Co., Ltd.

South Korea

AURINIA PHARMACEUTICALS INC

United States

Cubist Pharmaceuticals Inc

United States

Mezzion Secures $20 Million to Advance Phase 3 Trial of Udenafil for Rare Congenital Heart Disease

Mezzion Secures Strategic Financing to Advance Phase 3 Trial of Udenafil for Fontan Circulation

Mezzion Secures Key U.S. Patent for Udenafil in Fontan Patients, Extending Exclusivity to Early 2040s